| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | — | -60.9% |
| R&D Expense | $70.6M | — | -4.4% |
| SG&A Expense | $11.0M | — | -41.2% |
| Operating Income | -$78.6M | — | +7.4% |
| Net Income | -$73.3M | — | +4.9% |
| EPS (Basic) | -$0.41 | — | +10.9% |
| EPS (Diluted) | -$0.41 | — | +10.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $204.6M | +143.5% | +118.7% |
| Current Assets | $658.5M | +13.9% | -11.0% |
| Total Assets | $699.6M | +12.6% | -12.5% |
| Current Liabilities | $29.8M | +16.3% | -19.7% |
| Total Liabilities | $57.4M | +5.8% | -26.6% |
| Stockholders' Equity | $642.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$51.1M | — | +30.2% |
| Capital Expenditures | $384K | — | +0.0% |
| Investing Cash Flow | $32.9M | — | -22.5% |
| Financing Cash Flow | $138.8M | — | — |
| Free Cash Flow | -$51.5M | — | +30.0% |
| -10.9% |